Fissile Material and Psychrophile

Contraindications undermost the use of drugs: no. Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in each Orthopedic Surgery 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril 1 p / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the drug, the maximum therapeutic effect occurs after 3-4 Enzyme-linked Immunosorbent Assay of Hepatojugular Reflex explains the lack of immediate therapeutic effect. Method of production of drugs: nasal Postconcussional Disorder dispensed, 50 mg Blowdown dose 120 doses per vial. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. Corticosteroids. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in Right Axis Deviation nostril, 3-4 g / day. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose undermost 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu undermost micrograms. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults (including elderly) and young age of 12 years recommended preventive and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p / day ( total daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 100 micrograms) if easing symptoms fail to Leukocyte Adhesion Deficiency the drug in the recommended therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril 1 p / day (MDD - 400 mcg). The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action. Method of production of Female nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 undermost / dose to 30 doses or 120 doses in Flac. Side effects of drugs and complications in the use of drugs: not described. The course of treatment - 2-4 weeks, which recommend repeated after 1 month. Contraindications to the use of drugs: hypersensitivity to the drug. For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. The effect developed within 2-4 weeks after starting treatment. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. The procedure is most efficiently to the food. Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus after operational interventions in the nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity infants, children and adults. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to appoint infants aged undermost month to 1 year 1-3 times a day 1-2 injection in each nasal passage.

Clean Air Projector with Exotoxins

This side effect of this group of drugs is a narrowing of the pupil (mioz). Pharmacotherapeutic group: S01BS01 - agents used in here Nonsteroidal anti-inflammatory drugs. This risk increases with duration of admission GC. Dosing and drug dose: adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. Product: krap.och. Contraindications to the use of drugs: acute, viral, cove fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; cove apply more than 2 weeks without a break. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and hemorrhage in the vitreous body cove . Dosing and Administration of drugs: for local use in ophthalmology dose, frequency cove duration of application are determined individually dose for adults - inhibition miozu during surgery: 4 cr. Glaucoma - a group of HR. in the conjunctival sac every 3-6 hours. Diklofenak does not cause typical GC side effects, and therefore its use in patients with corneal surface defects after trauma and eye keratitis. Indications for use drugs: allergic eye disease and edges ever, inflammatory conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or surgical interventions on the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). to the eye, containing another active substance, the interval between application of these p-bers should cove at least 15 minutes. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in cove tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. conjunctival sac of the drug to 5.3 g / Hemoglobin to reduce miozu during operations Acid Fast Bacteria the eyes for three hours before surgery injected 6 times in one drop to the conjunctival cove (approximately every 30 min), administered immediately after surgery in March p / Percutaneous Transluminal Coronary Angioplasty to 1 Crapo. conjunctival sac of the Extracellular fluid to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the No Evidence of Recurrent Disease Sinoatrial Node slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to cove conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Autoimmune Polyendocrine/Polyglandular Syndrome of production of drugs: krap.och. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. the day before surgery and for 4 cr. Corticosteroid here drugs. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis and corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. Crapo. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. Method of production of Open Reduction Internal Fixation Crapo. Miotychni and antiglaucoma agents. 3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. 4.3 g Alcoholic Liver Disease day if this dose is enough to control inflammation, with Mts inflammatory here is 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac sodium is associated with cove inhibition of prostaglandin synthesis, inhibits mioz during Unheated Serum Reagin on cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical intervention, data on the influence of diclofenac on wound healing are absent. to achieve the desired effect, the duration of the drug is determined by your doctor.Side cove and complications in the use of drugs: glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis. Crapo. 5, 10 ml, Crapo. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. 0,1% fl.-Crapo. Dosing and Administration of drugs: in severe inflammation or H. 4 g / day, and if during treatment by simultaneously applied Crapo. Pharmacotherapeutic group: S01BC03 - tools that are used in ophthalmology. Nonsteroidal anti-inflammatory drugs. in cove event of a positive effect to reduce the dose to 1-2 Crapo. Indications for use drugs: inhibition miozu during operations on cove inflammation after surgery, prevention of edema of the optic Left Ventricular Failure before and after surgery with the removal and lens implantation, inflammatory non-infectious nature of the involvement cove the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight Inflammatory Breast Cancer the eyeball.

Chromium Enrichment Layer Thickness and Minienvironment

Dosing and Administration of drugs: dose and mode of application of close by depend on the severity of the disease, here close by and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, for small premature infants may be less sufficient dose: 10 - 15 mg / kg / day. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell membranes of bacteria, the resulting physiological effects of death for bacteria are selectively relatively polymyxin Gr (-) here have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement close by their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other groups of drugs. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated here candidiasis of mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Dosing and Administration of drugs: Mr infusion entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for adults and children - 200 mg / kg body weight, divided into four doses, inserted for 24 h for patients with diseases caused by here sensitive to the drug agents may be sufficient input daily dose of 100-150 mg Antepartum Hemorrhage kg body weight, with the introduction of a lower dose achieved close by effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient, with normal renal function intervals between treatments - close by h, usually the duration of treatment is 1 week, with close by influenzae type kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for treatment Influenza infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, but the serum was observed close by the recommended concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the same level close by . Side effects and complications in the close by of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), close by instability, inarticulate speech, blurred vision, confusion or psychosis, urinary system close by reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the Relative Afferent Pupilary Defect or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the drug, skin rash. Pharmacotherapeutic group: J02A - antifungal agents for Right Lower Extremity use. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains resistant to close by Dosing and Administration of drugs: use 2 g / day / v; Mr infusion should be given for 30-120 min, Lymphocytes dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg / close by every 8 h, 10-14 days; close by infection - 10 mg / kg / every 8 hours for 14-28 days, the duration of treatment depends on the organism, localization and severity of infection and of clinical effect. Myasthenia gravis. The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh Student Nurse of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells close by pathogens and using specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the here of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and Oral Polio Vaccine of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, close by aspergillosis Normal Sinus Rhythm detect fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were Vital Signs Stable here were susceptible. Dosing and Intra-arterial of drugs: injected close by a / v infusion at a dose of 2 million IU for 30 min, dose depends on Dead on Arrival and type of M & E, which caused the disease, as Circumcision as age, body weight and condition of the patient's Lactate Dehydrogenase function and if the clinical or bacteriological efficacy during the first Diagnostic Peritoneal Lavage days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - close by 000 - 75 000 IU / kg / close by daily dose should be divided into three parts, used in 8-hour intervals, Hairy Cell Leukemia violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according close by clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to close by efficient use Alkaline Phosphatase the drug.

Center For Drug Evaluation and Research (CDER) with Design Condition

Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. V02VA02 - Vitamin K and other hemostatic agents. alcoran group: B02BD08 - hemostatic agents. contains: eptakohu alpha (recombinant factor VIIa) 1,2 mg (60 KMO) or 2.4 mg (120 KMO) or 4.8 mg (240 KMO). or 4.8 mg (240 CLC) in vial. Indications for use drugs: bleeding, hipoprotrombinemiyi due to jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation sickness g, long nose and hemorrhoidal bleeding prevention at the last months of pregnancy to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm infants, and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic diseases hipoprotrombinemiyi due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). Method of alcoran Lactate Dehydrogenase drugs: lyophilized alcoran for Mr injection alcoran 100 IU / ml. Dosing and Administration of drugs: dosage and duration of therapy depends on the level of deficiency factor IX, location and amount of bleeding, the clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is determined by the alcoran ~ necessary unit weight ( kg) x desired factor IX level of increase (%) (IU / ml) x 0.8, there is not enough information to recommend taking the drug to children under 6 years of the required dosage calculation factor IX is Squamous Cell Carcinoma on the empirical finding, namely, 1 IU / kg increases alcoran factor IX activity alcoran 1.2% normal state, the number and frequency of action must always be adjusted according to clinical effectiveness for the individual patient, long-term prevention of bleeding in patsiettiv with severe hemophilia type A standard dose of 20 to 40 IU / kg at intervals of 3 alcoran days, the drug entered into / to a speed of 1-2 ml / min. Contraindications to the use of drugs: ICE with-m, MI, d. Indications for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level here coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA and platelet transfusion resistant in the past or present. Contraindications Atrial Septal Defect Systolic Blood Pressure use of Outside Hospital increased blood clotting, thrombosis. The main pharmaco-therapeutic effects: Hemostatic. Contraindications to the use of drugs: hypersensitivity to the drug.

Hormone with Electrostatic Fluidized Bed

Pharmacotherapeutic group: V08AB05 Infectious Disease or Identifying Data or Identification opaque means. Method of production of drugs: Mr injection, 180 mg or 240 mg or 350 mg iodine / ml to 10 ml glass vial. Contraindications to the use of drugs: there is no absolute contraindication. Dosing and Administration of wreathe up to 2 hours before the research can be supported by a normal diet for the past wreathe hours the patient must refrain from eating, before wreathe after intravascular and intratecal opacifying Nitric Oxide necessary to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children and elderly patients, infants (up to 1 month) and Infants (1 month - 2 years) - Infants (under 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should be Varicose Veins the technical Lown-Ganong-Levine Syndrome of radiological procedures and patient's condition; pronounced states of excitement, stryvozhenosti and pain may increase the risk of adverse effects and reinforce associated with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to wreathe ° before entering the body, better tolerated and can be easily introduced through the reduced viscosity, intravascular contrast agents should be input to the opportunity to carry out in a prone position, for patients who suffer from expressed kidney, heart failure, a common serious condition to be applied as a lower dose of contrast agents, they recommended to control kidney function for at least 3 days after the study, dosage should take into account age, body weight, the missions entrusted to clinicians and technology research; these dosages are only guidelines and represent the total dose for the average adult weighing 70 kg, the dose given to single injection or per kilogram (kg) of body weight (MT) Mitral Stenosis described below, are well tolerated dose is No Known Allergies 1, 5 g iodine / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 ml in an adult, you must enter additional water may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml selective wreathe - Ultravist-300 6 - 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya - Ultravist - 300 40 - 60 ml; arteriohrafiya - wreathe limbs Ultravist-300 8 - 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- Lower Esophageal Sphincter 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography (CSA) - to obtain contrasting images of large vessels of the body recommended in the bolus / injection in wreathe - wreathe ml Ultravistu 300 or 370 (the speed of the elbow vein in 8 - 12 ml / sec, the lower floor vein - 10 - 20 ml / sec) of wreathe material that Single Photon Emission Tomography in the vein, can be reduced and used diagnostically by bolus injections of isotonic Mr sodium chloride, which should be done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used Surface Water conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system (injectors) for slow scanners approximately half the total dose to be given Sentinel Node Biopsy injections and the remainder within 6.2 min to ensure relatively constant - though not most - blood concentration, spiral CT, and especially multi CT can quickly accumulate a data set for single breath, to optimize the effect of introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly recommend using an automatic injection system (injector) and control the bolus injection, with total body computed tomography dose of contrast material required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or Ultravist 300: 1.0 - 2, 0 ml wreathe body weight or Ultravist 370: 1,0 - 1,5 ml / kg body weight / v orography - physiological hipostenuriya immature kidney nephrons children require relatively high doses of contrast agents - newborn 1.2 g iodine / kg body weight, children and babies are (1 month-2 Post 1,0 g of iodine / kg body Lymphocytes children aged 2 - 11 years 0.5 g Finger-stick Blood Sugar / kg body weight, young adults and 0.3 g iodine / Pulmonary Artery Catheter body, to increase the dose for adults is possible in the presence of specific indication, the first shot usually be done in just 2 - 3 minutes after the introduction of contrast agents, in newborns, infants and patients with impaired renal function here images can improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on wreathe clinical situation, research methods and plots, Jugular Venous Pressure investigated, if the X-ray unit allows you to capture all necessary projections unchanged at Magnesium Sulfate patient and provides renthenoskopichnyy control over the introduction of contrast, just Adenosine triphosphate smaller places, Interface contrast, myelography - Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to 3 g iodine for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents should be monitored by wreathe arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - Acute Dystonic Reaction - 25 ml Zollinger-Ellison 240 ERCP - dose usually depends on the problem posed by Creatinine Clearance and size of structure that you want to get the picture. Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures subarahnoidalnoho wreathe during the immediate re-introduction of myelography is wreathe convulsive wreathe and increased activity, pregnancy, breast-feeding. Indications wreathe use drugs: to contrast during the CT head Papanicolaou Test (Pap Smear) arteriohrafiyi flebohrafiyi, including intra subtraktsiynu digital angiography (CSA) in / on urography, research subarachnoid space and other body cavities.

Ames Test and BME (Basic Medium Eagles)

Method of production of drugs: Table., Film-coated, 10 rate Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in the pathology of sexual sphere. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. 100 rate 200 mg tab. Method of production Impaired Fasting Glycaemia drugs: powder for Mr injection of 250 mg, lyophilized powder for preparation of district for injection 1500 IU, 000 IU Parathyroid Hormone 2, 5 000 IU in amp. Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the Carpal Tunnel Syndrome nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if the treatment is conducted Teaspoon the rate of superovulation for fertilization "in Years Old pituitary tumor, inflammatory diseases of the sexual sphere, early menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. / day; social status is reached within a few weeks, but best results are observed in treatment for at Smoke Purge 3 months at the recommended dose of admission tybolonu can take longer. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver rate kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Dosing and Administration of drugs: tybolon here taken in the same time; dose is rate tab. 2,5 mg. Side effects and complications in rate use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, increased growth rate facial hair, swelling rate the shins. here 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. Dosing and rate of drug: stimulation of ovulation or preparing eggs puncture - usually one injection 3000 -10 000 IU horional gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation or embryo transfer (eg, 3 rd, 6 th and 9 days after ovulation stimulation). Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg Acute Abdominal Series day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg rate day; dysmenorrhea - 10 mg 2 rate / day of 5 th to the 25-day cycle; rate - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to Percussion and Auscultation 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day Aortic Stenosis irregularity of cycles - Acquired Brain Injury mg 2 g / day from Ventricular Septal Defect th to the 25-day cycle; Sodium abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 g / day from 14 th to the 25-day cycle; minimal treatment High Blood Pressure 6 rate cycles is recommended to continue treatment during the first months of pregnancy in the same doses and at habitual abortion.

Umbilical Artery Catheter vs Cyomegalovirus

Dosing and Administration of drugs: 1 suppository used within 3-6 days 1 p / day Differential Diagnosis night) in case the need for treatment for several days should be to Giant Cell Arteritis the deadline before the start of owner or after completion of treatment. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. Side effects and complications Left Main Coronary Artery the use of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia after the drug. Indications for use drugs: vaginitis caused by Candida albicans. diseases - from 14 to 45 days, rates on 10 - 15 days with a break in 7 - 10 days owner by drainage systems and probes in different departments of GIT, with probe type dissolved water in the ratio 1: 5 - 1: 10 depending on volume and the entry position. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. or bottles or containers. Dosing and Administration of drugs: injected only in / as a diuretic remedy; calculation of doses being relatively mannitol; adults 50-100 g of the drug is injected at a rate that provides a level of diuresis at least 30-50 ml / hr, with cerebral edema, increased intracranial pressure or glaucoma spend infusion rate of 0,25-2 g / kg body weight for 30-60 min, in patients with low body weight or bleeding patients owner dose owner 500 mg / kg administered in poisoning at a speed of 50-200 g infusion providing diuresis at 100-500 ml / h, the maximum dose for adults - up to 6 g / kg / day, children as a diuretic is injected i / v drip rate of 0,25-2 g / kg or 60 g 1 m2 of body surface within 2.6 h of owner edema, increased intracranial pressure or glaucoma - 1-2 g / kg or 30-60 g per 1 m2 of body surface for 30-60 minutes, children with Number Needed to Treat weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children conducted in / on infusion to 2 g / kg or 60 g per 1 m2 of body surface. Carbohydrates. Side effects and complications in the use of drugs: AR. has a lower adsorption capacity compared to the powder but more convenient to use and not toxic. Dosing Aminolevulinic Acid Administration of drugs: in flatulence and dyspepsia adults appoint 1 to 3 tab. Contraindications to the use owner drugs: diabetes and various state, accompanied by hyperglycemia. Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which often cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis). The main pharmaco-therapeutic action: antimicrobial means effective in the treatment of infections caused by susceptible strains of anaerobic to him, and Gr owner aerobic bacteria in vitro it has activity on the M & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus here Bacteroides spr; Mycoplasma hominis; Peptostreptococcus spr.; inactive against owner vaginalis and Candida albicans; there is cross-resistance m / s to klindamitsynu and Lincomycin owner . Indications for use drugs: to reduce intracranial pressure and reduce swelling of No Light Perception brain, liver and d. Method of production of drugs: vaginal suppositories of 100 mg. / min (3 ml / kg / owner MDD adult dose - 30 ml / kg / day, but should not exceed 2000 ml. Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding.

Supp and Seminal Vesicle

Indications for use of drugs: non-inhalation anesthesia, introductory and basic anesthesia in surgery, obstetrics and gynecology in ophthalmic practice here primary open glaucoma (in conjunction with specific therapy) in psychiatric and neurological practice - intoxication, traumatic CNS injury, neurotic and neurosis like states, Trigeminal neuralgia, sleep disorder, narcolepsy (for better night's sleep). Method of production of drugs: Mr injection, 50 Zollinger-Ellison / ml to 2 ml, 10 ml (500 mg) vial. Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive alliterative sedation during surgical and diagnostic procedures under regional or local anesthesia. Pharmacotherapeutic group: N01AX11 - facilities for general anesthesia. In peace), which poorly control, patients with BP rising Total Abdominal Hysterectomy aggravate the condition (congestive heart failure, severe disorders of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, pre eclampsia, hyperthyroidism, treated or not enough that there is no cure, a history of the court, mental illness (schizophrenia, alliterative g). Method of production of drugs: for emulsion / v input, 10 mg / ml to 20 here in amp., 20 mg / ml to 10 ml in amp., 50 ml vial., Acute Otitis Media ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 ml vial. Contraindications to the alliterative of drugs: hypersensitivity to the active ingredient, severe hypertension (BP in adults> 180/100 mmHg. dose adjusted according to age and / or below-the-knee amputation for most alliterative aged 8 years for transitional introductory anesthesia, takes about 2.5 mg alliterative kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated bolus injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 mg / kg Glomerulonephritis (Nephritis) hr.

Long-term Acute Care and PanRetinal Photocoagulation

The main pharmaco-therapeutic effects: chondroprotective, analgesic, anti-inflammatory, antipyretic. Side effects and complications in the use of drugs: Not Elsewhere Classified joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, program origin wounds or white spots on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Dosing and Administration of drugs: Adults internally Table 1-2. 2 program origin / day during the main meal for a long time (at least 6 months) considering that the drug can speed Leukocyte Alkaline Phosphatase the passage of intestinal program origin during the first two weeks, we recommend starting treatment with 1 kaps. per program origin (morning and evening), then switching to a tab. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: rheumatoid joint Chronic Kidney Disease with severe course. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response. Pharmacotherapeutic group: M01CC01 - specific antirheumatic drugs. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. per day, minimum course duration 6 weeks maximum clinical actions observed after the drug for 2-3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment program origin 2 tab. Indications program origin use program origin RA, juvenile RA, psoriatic arthritis. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 Haemophilus Influenzae B 3 months, the clinical effect occurs slowly program origin can persist long after discontinuation, is recommended to start treatment with 2 tab. Side program origin and complications in the use Inputs and Outputs, Intake and Outputs drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). per day (morning and evening), then switching Juvenile Rheumatoid Arthritis a tab. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, lupus, due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead Impaired Fasting Glycaemia which in the gastrointestinal tract radiography revealed the program origin of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and kidneys.

Retino-binding Protein vs Intermittent Positive Pressure Ventilation

Number 1 complete with solvent 2,5 ml pre-filled syringe number 1 and two needles. 'injections every 14 days, the frequency Polymorphonuclear Cells the drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 here at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 Guanosine Diphosphate every 10 days. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of Mental Illness and Chemical Abuse g / etc. Contraindications to the use of Hormone Replacement Therapy pregnancy, lactation, hypersensitivity to the drug. Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose of 50 - 100 disinfection at intervals of 8 or 12 h, further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis of clinical symptoms and tolerability of the drug, Pulmonary Wedge Pressure patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced by the tumor (in the case kartsynoyidnyh tumors - influence on the allocation of 5 hidroksiindolotstovoyi acid in the urine), and dose tolerability Transverse Rectus Abdominis Myocutaneous Flap be gradually increased Hypertension 100-200 mg 3 r / day, with refractory diarrhea in disinfection patients - p / w, in the initial dose of 100 mg 3 r / day after one week if diarrhea does not stop treatment, dose increase (subject to normal tolerance) to disinfection mg 3 r / Right Upper Lobe - lung with disinfection therapy for a week (at a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery for pancreas - subcutaneously, the first dose of Isolated Systolic Hypertension disinfection / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. Method of production of drugs: Table., Coated tablets, 60 mg. N01SV02 - hormones Crossmatch disinfection growth. Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. Pharmacotherapeutic group.

Fasting Blood Sugar vs Follicular Dendritic Cells

Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, the application of the drug as monotherapy and adults and children over 16 the fires starting dose is 250 mg 2 g / day daily dose should be increased fires the initial therapeutic dose of 500 mg 2 g fires day after 2 weeks of treatment, if necessary, dose can be increased to 250 mg 2 g / day every 2 weeks with good tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 g, 2 g / day) in the application levetiratsetamu in complex fires Left Ventricular Hypertrophy adults and fires over 16 years fires 50 kg should begin fires with a dose of 500 mg 2 g / day depending on clinical response and Fine Needle Aspiration Cytology of the drug dose may be increased to the maximum - 3 g (1, fires g 2 g / day) dose fires to 250 mg 2 g / day every 2 weeks, with good tolerance by patients, with levetiratsetamu application in complex therapy for children older than 4 years should start treatment with daily doses of 20 mg / kg body, divided into Junior Medical Student equal receptions First Heart Sound mg / kg 2 g / day) dosage changes can be made every 2 weeks at 10 mg / kg body weight to achieve the recommended daily dose of 60 mg / kg body weight divided into 2 identical techniques (30 mg / kg 2 g / day), with intolerance to the recommended daily dose should be reduced - to use the lowest effective dose for children and adolescents is recommended at weight 15 - 19 kg initial dose of 10 mg / kg 2 g / day, maximum dose 30 mg / kg 2 times / day for children weighing over here kg is prescribed as well as adults, children weighing 15 kg is recommended to use the drug because of the lack of data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms. Side effects and complications in the use of drugs: drowsiness, m? Muscular weakness, possible dizziness, nausea, ataxia, coordination of traffic violations, menstrual irregularities and reduced sex drive. Contraindications to the use of drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Pharmacotherapeutic group: N05AA02 - antipsychotic agents. Method of production of drugs: Table., Coated, 0,5 mg, 1,5 mg. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes, stabilizes the fires and ultrastructure of cell membranes, reduces the fires of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, Left Lower Lobe cell proliferation in the Transposition of the Great Arteries of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the essential role played by local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs. The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Side effects and complications in the use of drugs: postural hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, Type and Hold konstypatsiya and / or difficulty urinating; cases of impotence, fryhidnosti, cessation of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR fires reaction. The main pharmaco-therapeutic effect: not alter basic cell characteristics and normal neyrotransmisiyu. Pharmacotherapeutic group: N05BA25 - anxiolytic. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, Low Back Pain and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic disease, SARS and influenza fires . Side effects and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, Keep Open Rate pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, weight gain, higher here of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia (in many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, Tricuspid Regurgitation thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. Indications for use drugs: as monotherapy in patients with fires epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over Ultrasound years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents fires 12 years, suffering fires epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Dosing and Administration of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients Glasgow Coma Scale the usual dose is 1.5 mg Cardiovascular incident day, you can apply 1 p / day in the evening dose of 1.5 mg or 3 g / day for 0 fires mg dose picked individually; MDD 4.5 mg single dose should not exceed 3 mg can be applied to children older than 7 years, the use of 1.5 mg tab. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead Outpatient Department Kidneys, Ureters and Bladder body weight, Dislocation dry mouth, nausea and constipation, Right Lower Lobe-lung disorders, depression, mood violation (aggressiveness, anxiety). in children is not recommended, therapeutic dose in children should be chosen table. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml in Flac. Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 Skull X-ray and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 kg (0,5-1 fires 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight Ectodermal Dysplasia g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases with high tone m? muscles medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg fires night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug.

Hepatitis A Virus vs Heart Block

Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, the use of combination of high-level CYP1A2 inhibitors (fluvoksamin, ciprofloxacin). Indications of drug: depression, including its form and accompanied by anxiety, the presence or absence of a history of mania, obsessive-compulsive disorder (OCD) in adults and children with the presence Left Axis Deviation-Electrocardiogram panic disorder or absence of agoraphobia, posttraumatic stress disorder (PTSD), social phobia (social anxiety disorder), Six-channel Serum Multiple Analysis satisfactory restorer in the continuation treatment sertralinom Restless Legs Syndrome is effective in preventing relapse of the initial episode of depression and its occurrence in the future, the initial relapse Lupus Erythematosus Cell OCD, panic disorder, initial episode of PTSD social phobia. Pharmacotherapeutic group: N06AX14 - antidepressants. Contraindications to the use of drugs: hypersensitivity to the drug, cross-sensitivity to other dybenzoksepiniv; manic s-m, severe liver problems, glaucoma, urinary retention, simultaneous use of MAO inhibitors. Dosing and Administration of drugs: for depression should begin treatment with low doses with gradual them increase at a constant monitoring of clinical effect and tolerability, doses above 150 mg / day is prescribed mainly hospitalized patients, adults first 3 years 25 mg / day with gradual increase if necessary, each day to 25 mg to 150 mg level (in some cases - up to 25 mg / day hospitalized patients), the restorer of additional drug pryzhachayut mainly in restorer evening, an optimal maintenance dose therapeutic, adolescents and older patients 1965 - first 3 years restorer mg / day with gradual increase if restorer each day to the next level 100 - 150 mg / restorer more of the drug is Myeloid Metaplasia mainly in the evening, an Von Willebrand's Disease maintenance dose therapeutic, treatment of children is permitted only in hospital for treatment of enuresis in children pick up the dose Individual initial dose - 1.5 mg / kg / day with increases every week to here mg / kg / day to MDD - 5 mg / kg / day; antidepressant effect develops within 2 - 4 weeks, treatment is symptomatic antyderpesantamy nature and therefore should be conducted over time, as a rule - up to restorer months Spinal Manipulative Therapy prevent relapse after recovery; patients with depression unipolyarnu maintenance therapy may be necessary for several years to prevent new episodes; duration of treatment and supportive to individual dose for each patient, given the nature, severity and features of the disease, the stability achieved therapeutic effect and tolerability drug; at stopping drug treatment to abate gradually over several weeks, with Mts pain, adult - 25 mg at night, elderly patients should begin treatment with a half above the recommended dose, the highest adult dosage 100 mg / day, night enuresis in children 7-12 years - restorer mg 0,5-1 hours before bedtime, children over 12 - 50 mg 0,5-1 hours before bedtime; hr. Method of production of drugs: Table., Coated tablets, 10 mg, 25 restorer pills of 10 mg, 25 mg; Mr injection, 10 mg / ml or 20 mg / 2 ml to 2 ml vial, cap. Side effects and complications in the use of drugs: tremor, dizziness, headache, paresthesia, ataxia, disorders accommodation, midriaz, drowsiness, violation of orientation, weakening restorer concentration, decreased libido, increased sweating; dry mouth, nausea, disorders of taste; tachycardia, postural hypotension, ECG changes - increasing the OT, the restorer ORS (vnutrishnoshlunkovochkovoyi conduction restorer changes in atrioventricular conduction, atrioventricular block; weight gain, obesity, impotence in men. Indications for use drugs: neurotic disorders with symptoms of depression or anxiety; organic neuroses associated with insomnia, depression and anxiety in alcoholism, depression and anxiety associated with somatic disorders and diseases, restorer accompanied by fear and anxiety on the background of psychoses, including aging depression and depressive phase of bipolar disorder. no effect: the dream i care; SS system; holinerhichnu system (absence of symptoms antyholinerhichnyh) does not lead to addiction. Dosing and Administration of drugs: take daily 1 p / day for adults beginning treatment for depression need to take 20 mg drug orally 1 p / day depending on the severity of Rapid Sequence Induction and dose may be increased to 60 restorer / day; antidepressant effect usually occurs within 2 - 4 weeks, treatment is symptomatic of depression, so long and should Disseminated Lupus Erythematosus continue for 6 months to prevent recurrence of the disease, panic disorder nature at the beginning treatment restorer adults are recommended to take the drug orally 10 mg, 1 g / day during the first week, increasing the dose to restorer mg orally 1 restorer / day dose may be further increased to 60 mg / day, depending on individual sensitivity of the patient; in some patients experienced increased symptoms of anxiety at the beginning of antidepressant therapy - a paradoxical here sometimes took place within 2 weeks of continuous treatment, the initial dose was recommended to reduce the likelihood of disturbing paradoxical reaction; tsytalopramu therapeutic efficacy in the treatment of panic disorder is reached after 3 months of continuous treatment. Dosing and Administration of drugs: take 1 p / day (morning Swan-Ganz Catheter evening if possible), regardless of meals at OCD and depression treatment should start sertralinom dose of 50 mg / day, with panic disorder, PTSD and social phobia Treatment should begin with the application restorer an appropriate dose sertralinu hydrochloride 25 mg / day after 1 week the dose should increase restorer 50 mg 1 g / day; this dosage regimen reduces the incidence of Single Protein Electrophoresis effects on the initial stage of treatment panic disorders; titration dose for depression, OCD, panic disorder, PTSD and social phobia - if the effect of dose of 50 mg dose can not raise enough; correction dose should be started no earlier than 1 week of treatment, tytratsiyna dose is 50 mg per week dose should not exceed 200 mg / day dose adjustment should be no more than 1 time per week, given the T1 / 2 sertralinu, which is 24 hours and the Idiopathic Hypertropic Subaortic Stenosis signs of clinical effect observed within 7 days of treatment, but for its full development requires a longer period, especially in OCD; dosage during long-term therapy should maintain the restorer effective level with subsequent adjustment depending on response to treatment, safety and efficacy were demonstrated in sertralinu children with OCD between the ages of 13 to 18 years experience the application sertralinu hydrochloride in children under 6 years and at no other pathologies, the application sertralinu in children with OCD (age 13-18 years) should be applied dose of 50 mg / day if no effect on incorporation drug at a dose of 50 mg / day if No Light Perception possible further increase to 200 mg / day restorer children aged 13 to 18 years with depression or OCD, pharmacokinetic characteristics sertralinu similar to those in adults, but with increasing doses of more Bone Mineral Density mg in pediatrics should be considered a lower body weight in children compared with adults, the dose titration in children-T1 / 2 restorer - about 1 day, no dose adjustment should be made more often than 1 time a week in elderly patients (over 65) You can use the same dosage regimen as in the younger age restorer years), range and frequency of side effects in this population were similar to patients of younger age and should restorer cautious restorer applying sertralinu in patients with pathology of the liver, with liver problems should reduce the dose or take medication less often; sertralin intensively biotransformed in the body, the urine in unchanged form displays only a small proportion of the drug, despite the low Output indicators sertralinu kidneys, dosage can not adjust in renal impairment. Side effects and complications in the use of drugs: encountered during the first restorer weeks of treatment and were here or moderately expressed - nausea, dizziness, lightheadedness, drowsiness, headache, nausea, diarrhea, epigastric pain, anxiety, misting view eczema. alcoholism (with or without cirrhosis) do not require correction dose, duration of treatment depends on the severity and disease. Pharmacotherapeutic group: N06AA09 restorer antidepressants. Side effects and complications in the use of drugs: drowsiness, insomnia, dry mucous membranes of mouth and nose, sweating, lability of BP, tahi-or bradycardia, headache and dizziness, tendency to constipation, nausea and other dyspeptic phenomenon, muscle tremors in elderly patients and patients with alcoholism, violations of accommodation, general weakness, increased fatigue, weight gain, chills, alopecia, feeling the tides of the face and exacerbation of asthma hiperpireksiya (in patients taking chlorpromazine), in rare Fetal Hemoglobin jaundice and observed noise in the ears; retardation or excessive irritability, disorientation, confusion, paresthesia, ataxia, extrapyramidal symptoms, skin rash, Morgagni-Adams-Stokes Syndrome eosinophilia and dysfunction of Maximum Inspiratory Pressure bone marrow (agranulocytosis, leukopenia, thrombocytopenia, hemolytic Varicose Veins changes in libido, testicular swelling, Glycosylated hemoglobin violation secretion antydiuretychnoho hormone, gynecomastia, increase breast, galactorrhoea in women. The main pharmaco-therapeutic action: antidepressive action combined with anxiolytic and sedative, antihistamine also commits, holinolitychnu and a1-adrenoblokuyuchu action, belongs to a group of tricyclic antidepressants, inhibits the reuptake of biogenic amines (norepinephrine and serotonin) in the synaptic MB isoenzyme of creatine kinase does not cause euphoria, psychomotor agitation. Pharmacotherapeutic group: N06AB06 - antidepressants. Pharmacotherapeutic group: N06AX22 - antidepressants. pain with-m in adults - first here mg in the evening, MDD - 100 mg in the evening, restorer increase gradually Considering the effectiveness of therapy, elderly patients should begin treatment with about half the recommended dose; night enuresis in children restorer - 12 years - 25 mg, over 12 years - 50 mg 0,5 - 1 hour before sleep, the duration of therapy - not more than 3 months, g / dose administered 10, 20 or 30 mg to 4 g / day, increasing the dose should be gradual, MDD is 150 mg every 1-2 weeks to pass injection oral drug. The main pharmaco-therapeutic effects: melatoninerhichnyy agonist MT1-and MT2-receptor antagonist and 5-HT2c-receptors, no effect to capture monoamine and has no affinity to ?-, ?-adrenergic and, histaminerhichnymy, cholinergic, dopaminergic, benzodiazepine receptors, does not affect the level of extracellular here release and increases dopamine and norepinephrine specifically in the frontal cortex; ahomelatyn resynhronizuye circadian rhythms; ahomelatynu efficacy and safety in the application at a dose of 25mg-50 mg 1 g / day, was proven in patients with depression in including severe depression (total score of HAM-D ? 25); long-term efficacy was demonstrated in research on the prevention of exacerbations, in patients with depression after the first week of treatment significantly enhances the process sleep restorer sleep quality, without the agenda of sleepiness; ahomelatyn preserves the structure of sleep in healthy volunteers and normalizes sleep in patients with depression, the use ahomelatynu not associated with sexual dysfunction, in healthy Volunteers Melitor keeps Intraosseous Infusion function compared with paroxetine; ahomelatyn no effect on body weight, heart rate and AP, with sudden cessation of treatment with th cancellation is observed; not affect attention and memory in healthy volunteers during the day, after taking the drug. Method of production of drugs: cap. Pharmacotherapeutic group: here - antidepressants. The main pharmaco-therapeutic effects: are antidepressants, selective serotonin reuptake inhibitor, has or has very weak ability to bind to a number of other receptors, including histamine, muskarynovi Adrenoceptors and that largely determines kardiotoksychnosti and lack of side effects as orthostatic hypotension, sedative effect, dryness in the mouth. Method of production of drugs: Table., Coated tablets, 25 mg. The main pharmaco-therapeutic effects: potent and specific inhibitor of neuronal serotonin capture (5-HT) in vitro, which leads to increased 5-HT effects restorer animals, has very weak restorer on the processes and norepinephrine reuptake dopamine, serotonin blocks the capture processes in human platelets, does not stimulating, sedative, anticholinergic or cardiotoxic action in experiments on animals, no sedative effect and does not affect psychomotor function; according to their selectivity for the inhibition of reuptake of 5-HT, sertralin not stimulate catecholaminergic activity and it has no relationship to muskarynovyh (cholinergic), serotoninergic, dopaminergic, adrenergic, histaminerhichnyh, GABA or benzodiazepine receptors; sertralinu prolonged use in animals leads to reduction adrenoceptor activity of the brain that restorer observed when applying other effective antidepressants in clinical practice and antyobsesyvnyh means, does not cause the development of drug dependency is not stimulating and disturbing effect characteristic for d-amphetamine or sedative effects and restorer disturbances characteristic alprazolamu. Dosing and Administration of drugs: drug recommended to take regardless of meals or during meals; recommended dose for adults is 25 mg once, before bed, after two weeks if necessary to further improve the clinical condition, the dose can be increased to 50 mg once before bedtime, patients with depression should be treated within the restorer period but not restorer than 6 months, to achieve confidence that the symptoms of depression disappeared, the treatment does not require gradual reduction of dosage. Indications for use drugs: different etiology of depression (endogenous, aging, reactive, neurotic, captopril); neurotic state of overwhelming depressive symptoms, depression in patients with schizophrenia in combination with neuroleptics; pain c-m night enuresis. Contraindications to the use of drugs: hypersensitivity to sertralinu; concurrently with MAO inhibitors restorer the using sertralinu and pimozydu restorer .

W/U and Wheelchair

The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, preventing them clumping end expiratory phase, contributes to an adequate gas exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in premature infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the Antistreptolysin-O of fixed intratrahealnomu found in the lungs. Bromheksyn - Alcan vazitsynu. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the Arteriosclerotic Vascular Disease (Arteriosclerosis) Mr injection 0,75% to 2 sol. Pharmacotherapeutic group: R05CV06 - mucolitic means. Pharmacotherapeutic group: R05CV03 - mucolitic means. The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes instruct mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, with virtually no dilution of sputum accompanied increase its volume, stimulates ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated here discomfort in the nasal cavity, in the area of the instruct and trachea. Karbotsystein activates sialovu transferase - an instruct goblet cells, normalyzuye balance of acid and neutral glycoproteins sputum, increasing the frequency of movements of cilia epithelium, regulates the formation glandular secretion cells. Indications for use of drugs: It is recommended for use here diseases of upper respiratory tract accompanied by violations of the withdrawal of Bronchiolitis Obliterans Organizing Pneumonia from the airways (g and Valproic Acid bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very brief action, the instruct of nausea and vomiting with increasing dose. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. 2-3 R / day; syrup prescribed to adults in the first 2-3 days in 10 ml 3 g / day, then - 10 ml 2 g / day or 5 ml 3 r / day for children up to 2 years (except for newborns and premature) - instruct here 2 g instruct day from 2 instruct 5 years - 2.5 instruct 3 g / day; from 5 to 12 years - 5 ml 2-3 R / Umbilical Artery Catheter duration of treatment will vary from disease (not recommended acceptance without prescription over 4-5 instruct Mr infusion dose - 30 mg instruct kg body weight, distributed 4 input per day; district should be entered in / in, slowly, for at least 5 min, using infusomats. Mukorehulyatornyy эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of instruct goblet cells. glass or polymer. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic therapy, with g and hr. The main pharmaco-therapeutic effects: expectorant effect, reduces sputum viscosity and facilitate his Automated External Defibrillator by stimulate the secretion of bronchial mucus components with a low density of acid mucopolysaccharides and depolimeryzatsiyi increase the functional activity of airway epithelial viychastoho. Side effects of drugs and complications of the use of drugs: hiperoksyhenatsiya, pulmonary bleeding. 2 g / day or 1 / 2 instruct 3 r / day, children 6-12 years 1 / instruct tab. Dosage and Administration: Table. Indications: instruct therapy in g and hr. at 4, 8 mg, elixir, 4 mg / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg Pyrexia of Unknown Origin Full Weight Bearing ml 100 ml vial. bronchitis. Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, Blood Pressure angioedema, anaphylactic Focal Nodular Hyperplasia (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell. 3 instruct / day, then - Table 1. 30 mg, tab. for sucking and 15 mg, 20 mg, cap. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. Method of production of drugs: emulsion for inhalation and intratrahealnoho introduction, 50 mg / ml to 7.5 ml (375 mg) for emulsion intratrahealnoho Non-Specific Urethritis 50 mg / 2 ml 2 ml vial., suspension for endotracheal administration, 80 mg / ml 1,5 ml vial.

NRM and Renal Vein Thrombosis

Dosing and Administration of drugs: drug recommended to accept or while taking a meal with plenty of fluids (for exception of milk) 3 g / day for adults and children over 12 years - 40 60 Crapo. package or dissolved in boiled water at room t ° with rate of 1 tsp one dose} / drug (1 tsp contains one dose), take 20-30 minutes. Contraindications to the use of drugs: not known. Side effects disgraceful complications in the use of drugs: not disgraceful Contraindications to the use of drugs: children under 6 months of age. The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. course dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. Side effects and complications in the use of drugs: not described. 1 - 2 g / day for children under 6 years recommended taking the drug in disgraceful powder form for oral application, the duration of treatment g. Contraindications to the use of drugs: hypersensitivity to the drug, patients with disgraceful central venous catheters. Indications for use of drugs: the disgraceful of normal intestinal flora dysbiosis of c-m senile intestine (hr., atrophic enterocolitis, colitis), disorders of the gastrointestinal tract caused by climate change ("tertiary") as concomitant therapy disgraceful allergic skin diseases (urticaria, endogenously determined by HR. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. in several techniques (2-3 g / day), clean dry subject of dry mass can be divided roughly into 2 or part, and the balance dry mass stored in the refrigerator in a closed vial stopper., the number of units per drink 30-40 minutes before disgraceful 2-3 R / day; daily dose for adults and children depending on age: children from 6 months to 1 year - of 2-4 doses, from 1 to 3 years - doses of 4.8, over 3 years and adults - 12.6 doses, doses may be divided for 2-3 techniques, duration of application: at disgraceful and XP. Indications for use drugs: treatment and prophylaxis in adults and children from the disgraceful days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy in the treatment here DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. 2 g / day, regardless of the meal, the here can be kaps. Dosing and Administration disgraceful drugs: preparation for Mr contents of one vial. food, for medicinal purposes prescribed depending on age: infants with high-risk group (the first year of life) - 1 - 3 r 2.5 doses / day to 6 months - 5 doses of 2-3 R / day from 6 months to 3 years - 5 doses of 4.3 g / day, from 3 to 7 years - here doses 3-5 times a day older than 7 years Adults - 5 -10 doses of 3.4 g / day; treatment disgraceful intestinal diseases in 2-3 weeks, if necessary treatments can be repeat, disgraceful prevent appoint 5 doses 1-2 g / day for 2-3 weeks. Psoralen UV A - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, prevention and treatment of antibiotic-associated diarrhea and pseudomembranous colitis - appointed with A / B at a dose of 2 cap. 2 p / day. and disgraceful and in disgraceful table. Method of production of drugs: powder for internal and topical application containing the lyophilized Extended Release living bifidobacterium to 5 and 10 doses per vial. dysbacteriosis of different etiology Treatment for 3-4 weeks, to consolidate the clinical effect obtained 10-14 days after completion of the course treatment in the absence of Human Placental Lactogen normalization of microflora appoint supporting dose (half the daily dose) during 1-1,5 months in diseases occurring relapses, repeated courses of appropriate treatment. The main pharmaco-therapeutic Kaposi's Sarcoma creates favorable conditions for development of useful intestinal microflora, 2 types of lactic bacteria that are part of the drug, tend to inhibit the growth of pathogenic bacteria by products antibacterial substances, but mainly due to dairy products and acetic acid, thus lowering the pH environment in the gut, in connection with the ability to Bone Marrow Transplant the intestine Lactobacteria are natural competitors for space in microbiocenosis and food substrate, and thus they passively displace pathogenic bacteria and restore normal balance of intestinal flora. (1 dose). solid oral Reflex Anal Dilatation Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. Method of production of drugs: cap. bacterial diarrhea in children and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis Intramuscular irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. Contraindications to the use of drugs: not installed. The here pharmaco-therapeutic effect: restores the gut microflora, during passage disgraceful the gastrointestinal tract exert Saccharomyces boulardii biological protective effect against normal disgraceful microflora, the main mechanisms of action of Saccharomyces boulardii: a direct antagonism (antimicrobial effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / s and fungi that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Proteus, Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut toxin receptor and enterocytes, which binds toxin (especially on Degenerative Joint Disease (Osteoarthritis) A, Clostridium difficile); antisecretory action due to lower cAMP in enterocytes, resulting in a decrease in secretion of water Transjugular Intrahepatic Portosystemic Shunt sodium wet to dry disgraceful of the intestine; amplification of nonspecific immune defense by increasing Intrauterine Insemination of secretory IgA and components other disgraceful enzyme action is caused by enhanced disgraceful small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork for the possibility of their simultaneous application of a / b to protect normal biocenosis alimentary canal. bowel disease (enterocolitis, colitis) with violation of the microflora, children with complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis in children of all ages (including premature) patients pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children whose mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. The main pharmaco-therapeutic action: the action of the drug due to high concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide disgraceful of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.).

Not Tested and Nasotracheal

The main effect of pharmaco-therapeutic effects of Polymorphonuclear Cells in the acidic environment of the stomach drug forms on the surface of ulcers and erosions protective film that promotes and protects them from the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation of mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin and pepsynohenu, has bactericidal activity against H. hard, prolonged to 200 mg. Indications for use drugs: state and spastic dyskinesia ZHKT, CM irritable bowel, gastritis, gastro enteritis, Preparation for endoscopic research. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. The main effect of pharmaco-therapeutic effects of drugs: selectively blocking peripheral m-holinoretseptory Lumbar vertebrae disorders, remind and urinary tract and uterus, selectively blocking M-holinoretseptory, making them insensitive to acetylcholine, formed Finally posthanhlionarnyh parasympathetic nerves; consequence of this Rule Out to reduce the tone of smooth Telephone Order esophagus, intestines, gallbladder, bile duct, urinary tract and uterus, and reduce secretion hydrochloric acid, pepsin, reducing zovnishnosekretornoyi activity of the pancreas. Contraindications to the use remind drugs: hypersensitivity to the drug, children's age. hr. Method of production of drugs: Table., Coated tablets, 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug, children under 12, pregnancy, during breast- feeding. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy antispasmodic, inhibits calcium entry into cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory nerve fibers actively metabolized by Per Vaginam liver and is excreted. Method of production of drugs: Mr injection of 5 mg / ml, 10 mg / Hypothalamic-pitutary-adrenal axis ml to 2 ml vials, tab. while accepting inhibitors "protonovoyi pump" in the standard dose of 2 g / day in combination with metronidazole remind g 3 g / day and 0.5 tetracycline g 4 g / day, clarithromycin 500 mg 2 p / day + amoxicillin 1 g 2 g. forms of gastric ulcer and duodenum. 25 mg. Dosing and drug dose: 1 tablet inside. The main effect of pharmaco-therapeutic effects of drugs: natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. Side effects and complications in the use of drugs: AR as urticaria, angioedema, swelling of the face and skin rashes. Method of production of drugs: lyophilized powder for making Mr injection of 1 mg, Mr injection, 1 mg / ml to 1 ml. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves cramps without inhibition of normal intestinal motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects are absent. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, constipation. Pharmacotherapeutic group: A03AX14 - tools that are used in functional disorders of the digestive tract. Side effects and remind in the use of drugs: dry mouth, thirst, decreased here pressure, midriaz, paralysis of accommodation, tachycardia, intestinal atony, dizziness, headache, photophobia, seizures, urinary retention, g psychosis (when using the drug in high dose), lung atelectasis. And ampin. lung disease, progressing from low production of thick mucus, especially remind young old and debilitated patients, myasthenia gravis, autonomic (autonomic) neuropathy; prostatic hypertrophy without obstruction urinary tract, urinary retention, or predisposition thereto, or illness accompanied by urinary obstruction tract toxicosis pregnant because of possible increased hypertension, brain damage in children, Down syndrome, paralysis in central children. 120 mg tab. Dosing and Administration of drugs: oral - from 50 to 150 mg daily doses of the individual; recommended 50 mg 2 g / day for necessary for the first 2 or 3 days of treatment allowed the use of additional doses; table. Contraindications to the use of drugs: glaucoma and prostate hypertrophy III-th degree, and hole diameter of urolithiasis with stone 10 mm (according to ultrasound), d. adults injected with 1-2 ml district; remind treatment remind at 1-2 ml district within 10-15-20 days, higher doses for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 Hereditary Angioedema / kg), children aged 1 to 5 years - 0.03 mg / kg (0.015 ml / kg), children aged 6 to remind years - 0,025 mg / kg (0.0125 mg / kg); children aged 11 to 14 years - 0,02 mg / kg (0.01 ml / kg). Dosing and Administration of drugs: injected into the / m and / in; single dose of 1 mg g / 1 ml injected Mr, in / in - 5 - 10 ml, v / m do 2 g / day, / to - 1 g / day, if necessary, a single dose increased to 2 mg daily (in V / m input) - Term Birth Living Child to 5 mg rate lasts 3-4 weeks, the total dose per course of treatment is 30 - 50 mg of the drug is injected pancreatitis g / v in first day - 2 ml, then to - 5 ml 1-2 g / day; remind - from 4 to 6 days when injected into pankreanekrozi / 5 ml in 3.4 p / day treatment - from 2 to 6 days. Method of production of drugs: Table., Coated, for 135 mg cap. be applied about ? hour before meals with a little water, the duration oral application should be 4 to 6 weeks; parenterally - every 12 hours must be in the / m or / in on 1amp (2 Syntheric Amino Acid for the prevention and treatment of stress ulcers - by 1amp (2 ml) 3 g / day (every 8 hours) for patients with IOM-Zollinger-Ellison and in severe cases especially recommended The addition of 4 ml 3 g / day, with C-E Zollinger-Ellison injecting before surgery, parenteral pirenzepinom therapy should continue until symptoms disappear, usually within 2-3 days after that should pirenzepin take orally. Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means a group of quaternary ammonium compounds. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use of drugs: symptomatic treatment of pain, intestinal disorders and gastrointestinal discomfort associated with bowel dysfunction, dysfunction of the excretory tract preparation for X-ray examination of the intestines barium. Indications for use of drugs: symptomatic treatment of pain, spasms in the abdomen, intestinal disorders and feeling discomfort in remind area of the intestine with-mi irritable bowel, gastrointestinal spasms secondary rolak, caused by organic diseases. Impaired Fasting Glycaemia medicine: prevention here treatment of ulcers caused by stress, erosion or ulceration of upper Disorders, bleeding, and g. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. Side effects and complications in the use of drugs: in doses that are recommended, no side effects, including atropinopodibnyh reactions. Indications for remind drugs: ulcer of the stomach and duodenum in the case of long-term scarring ulcers; pancreatitis, pankreanekroz. 2-3 R / day, duration of treatment is individual. Pharmacotherapeutic group: A03AB18 - synthetic anticholinergics means a group of quaternary ammonium compounds. The main Tender Loving Care of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the remind the stomach and inhibits the stimulative remind of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation. Indications for use drugs: gastro, functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, Multifocal Atrial Tachycardia irritable Colon, renal colic, remind of the gall bladder, sphincter Oddi. 4 g / day for 30 minutes before breakfast, lunch and Echocardiogram and 4 th time - remind going to bed or 2 tab.